Clinical trial
Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial
NCT00196690 · Gabinete Berthier y Martínez, Other · Completed
Key facts
| NCT number | NCT00196690 |
|---|---|
| Title | Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial |
| Official title | Treatment With Donepezil of Chronic Aphasia and Sensorimotor Deficits Associated to Cerebrovascular Accidents: a Double-Blind,Placebo-Controlled, Randomized Parallel Trial. |
| Lead sponsor | Gabinete Berthier y Martínez, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stroke, Aphasia |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 30 |
| Start date | Feb 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: